Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of KOMINOX (KML001) in Refractory or Recurrent Non-Hodgkin's Lymphoma
KCT0000737Phase 2Recruiting
- Sponsor
- Komipharm
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium arsenite in non-Hodgkin lymphoma (NHL), sponsored by Komipharm. Started Mar 2013; status: recruiting.
02
Drugs
sodium arsenite
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on KCT0000737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000737.